DongKoo Bio & Pharma Co., Ltd. (KOSDAQ:006620)

DongKoo Bio & Pharma Revenue

DongKoo Bio & Pharma had revenue of 58.06B KRW in the quarter ending March 31, 2026, a decrease of -1.04%. This brings the company's revenue in the last twelve months to 242.08B, down -0.68% year-over-year. In the year 2025, DongKoo Bio & Pharma had annual revenue of 242.69B, down -2.64%.

• Revenue (ttm): 242.08B
• Revenue Growth: -0.68%
• P/S Ratio: 0.48
• Revenue / Employee: 599.20M
• Employees: 404
• Market Cap: 115.47B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	242.69B	-6.59B	-2.64%
Dec 31, 2024	249.27B	33.59B	15.57%
Dec 31, 2023	215.69B	20.70B	10.62%
Dec 31, 2022	194.99B	39.84B	25.68%
Dec 31, 2021	155.15B	15.93B	11.45%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 1, 2026

Data Sources Report a data error